Showing results (101-110 of 901) with videos related to
Sort By:
Pageof 91
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|December 3, 2014
Comprehensive phenotyping of regulatory T cells after liver transplantationAnna Gronert Álvarez, Paraskevi Fytili, Pothakamuri V Suneetha, et al.Gut|June 8, 2010
Managing HBV in patients with impaired immunityKarsten Wursthorn, Heiner Wedemeyer, Michael P MannsExpert Opinion on Pharmacotherapy|February 20, 2010
Treatment of HBV/HCV coinfectionAndrej Potthoff, Michael P Manns, Heiner WedemeyerJournal of Hepatology|September 20, 2016
Future landscape of hepatitis C research - Basic, translational and clinical perspectivesDarius Moradpour, Arash Grakoui, Michael P MannsCell and Tissue Research|September 29, 2007
Stem cells in liver regeneration and therapyTobias Cantz, Michael P Manns, Michael OttGastroenterology|April 28, 2012
Pathogenesis and treatment of hepatitis e virus infectionHeiner Wedemeyer, Sven Pischke, Michael P MannsCurrent Medicinal Chemistry|November 17, 2004
Influence of mutations in the hepatitis B virus genome on virus replication and drug resistance--implications for novel antiviral strategiesFrank Tacke, Michael P Manns, Christian TrautweinBest Practice & Research. Clinical Gastroenterology|February 4, 2009
Natural history: the importance of viral load, liver damage and HCCKarsten Wursthorn, Michael P Manns, Heiner WedemeyerCurrent Opinion in Investigational Drugs (London, England : 2000)|February 7, 2009
Boceprevir, an NS3 serine protease inhibitor of hepatitis C virus, for the treatment of HCV infectionIngmar Mederacke, Heiner Wedemeyer, Michael P MannsPostgraduate Medical Journal|March 2, 2011
Republished paper: Managing HBV in patients with impaired immunityKarsten Wursthorn, Heiner Wedemeyer, Michael P MannsPageof 91